Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Jul 16;18(3):676–683.e3. doi: 10.1016/j.cgh.2019.07.017

Table 2:

Area under the curve (with 95% confidence interval) was not influenced by baseline differences in clinical covariates, but was significantly higher in samples collected without protease inhibitor

Covariate No Yes P value
Age>65 0.91 (0.82-1.00) 0.89 (0.8-0.99) 0.7871
Male 0.93 (0.84-1.00) 0.88 (0.78-0.98) 0.5175
Diabetes 0.86 (0.76-0.96) 0.96 (0.88-1.00) 0.1264
Inhibitor 1.00 (1.00-1.00) 0.89 (0.82-0.96) 0.0036